Skip to main content

Advertisement

SpringerLink
Log in

Efficacy of Sentinel Lymph Node Biopsy in Detecting Axillary Metastasis in Breast Cancer Using Methylene Blue

  • Original Article
  • Published:
Indian Journal of Surgical Oncology Aims and scope Submit manuscript

Abstract

Breast cancer is the leading malignancy and the second leading cause of cancer-related deaths. Axillary lymph node status is a very important prognostic factor in breast cancer patients; nodal evaluation is therefore a critical part of breast cancer management. Axillary lymph node dissection results in significant morbidity. Sentinel lymph node biopsy (SLNB) is being used in many centers to stage the axilla in planning axillary dissection management of patients and hence plays an important part in reducing morbidity among patients with carcinoma breast. The objectives of this paper is to study the (1) efficacy of sentinel lymph node biopsy in detecting axillary metastasis, (2) location of sentinel lymph node in the axilla, (3) rate of involvement of sentinel lymph nodes, and (4) incidence of skip metastasis. Thirty-five patients with breast cancer with clinically node-negative axilla were selected for the study. Methylene blue dye was injected intralesional and perilesional 20 min prior to surgery. All patients underwent modified radical mastectomy with sentinel lymph node biopsy and axillary dissection and after pathological examination diagnostic statics, namely sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy were computed. Sentinel lymph node was identified in all of these patients. Sixty percent patients had pathologically positive lymph nodes in the axilla. 90.48% patients of these had sentinel lymph nodes positive for malignant cells. Incidence of skip metastasis is 9.52%. 88.57% patients had sentinel lymph node mapped to level I lymph nodes. Sensitivity of SLNB is 90.48%, specificity is 85.71%, PPV of is 90.48%, NPV is 85.71%, and accuracy is 88.57%. Sentinel lymph node biopsy is an effective method of staging the axilla and deciding on axillary clearance in patients of carcinoma breast. Unnecessary axillary dissection and associated complications can be prevented in most of patients due to sentinel lymph node biopsy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomized trials. Lancet 365:1687–1717

    Article  Google Scholar 

  2. Gervasoni JE Jr, Taneja C, Chung MA, Cady B (2000) Axillary dissection in the context of the biology of lymph node metastases. Am J Surg 4:278–331

    Article  Google Scholar 

  3. Halsted WS (1895) The results of operations for the cure of cancer of the breast performed at the Johns Hopkins Hosp. Bull 4:297–323

    Google Scholar 

  4. Giuliano AE, Kirgan DM, Guenther JM, Morton DL (1994) Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220:391–401

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Morton DL, Wen D, Wong JH et al (1992) Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127:392–399

    Article  CAS  PubMed  Google Scholar 

  6. Rietman JS, Dijkstra PU, Geertzen JH et al (2004) Treatment-related upper limb morbidity 1 year after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast cancer. Ann SurgOncol 11:1018–1024

    CAS  Google Scholar 

  7. Somsekhar SP, Zaveri Sabber S, Udupa Venkatesh K, et al. Sentinel lymph node biopsy in early breast cancer using methylene blue dye and radioactive sulphur colloid: a single institutional Indian experience. Ind J Surg 2008; 70:111–119.

  8. Nosheen F, Zaman MU, Maqbool A, Khan SH, Riaz N (2013) Lower incidence but more aggressive behavior of right sided breast cancer in Pakistani women: does right deserve more respect? Laterality and aggressiveness of tight sided breast cancer. Asian Pacific J Cancer Prev 14(1):43–45

    Article  Google Scholar 

  9. Turner RR, Ollila DW, Krasne DL, Giuliano AE (1997) Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg 226(3):271–278

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Deo SVS, Atul S, Shukla NK, et al. Sentinel lymph node biopsy assessment using intraoperative imprint cytology in breast cancer.

Download references

Author information

Authors and Affiliations

  1. Department of General Surgery, Shri Vasantrao Naik Government Medical College, Yavatmal, Maharashtra, India

    Vipul V. Nandu & Milind S. Chaudhari

Authors
  1. Vipul V. Nandu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Milind S. Chaudhari
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vipul V. Nandu.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nandu, V.V., Chaudhari, M.S. Efficacy of Sentinel Lymph Node Biopsy in Detecting Axillary Metastasis in Breast Cancer Using Methylene Blue. Indian J Surg Oncol 8, 109–112 (2017). https://doi.org/10.1007/s13193-016-0616-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13193-016-0616-z

Keywords

Search

Navigation